Research / A / Fundamental state Inspectable configuration
State dimensions Filing 0001090872-18-000015 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
148.88% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
2.74% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
16.38% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
7.99% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
51.79% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
54.95% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
18.70% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
8.06% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.08% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 40 states Self-history eligible
Oct 31, 2021 8/8 normalized Level 3 Jan 31, 2022 9/9 normalized Level 3 Apr 30, 2022 9/9 normalized Level 3 Jul 31, 2022 9/9 normalized Level 3 Oct 31, 2022 9/9 normalized Level 3 Jan 31, 2023 9/9 normalized Level 3 Apr 30, 2023 9/9 normalized Level 3 Jul 31, 2023 9/9 normalized Level 3 Oct 31, 2023 9/9 normalized Level 3 Jan 31, 2024 9/9 normalized Level 3 Apr 30, 2024 9/9 normalized Level 3 Jul 31, 2024 9/9 normalized Level 3 Oct 31, 2024 9/9 normalized Level 3 Jan 31, 2025 9/9 normalized Level 3 Apr 30, 2025 9/9 normalized Level 3 Jul 31, 2025 9/9 normalized Level 3 Oct 31, 2025 9/9 normalized Level 3 Jan 31, 2026 9/9 normalized Level 3 Apr 30, 2026 9/9 normalized Level 3 Jul 31, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 148.51%
Current 148.88%
Delta 0.37% Capex Intensity Decreased
Previous 3.98%
Current 2.74%
Delta -1.24% Cash Generation Decreased
Previous 25.12%
Current 16.38%
Delta -8.75% Growth Decreased
Previous 9.44%
Current 7.99%
Delta -1.45% Inventory Pressure Increased
Previous 49.25%
Current 51.79%
Delta 2.53% Margin Increased
Previous 53.40%
Current 54.95%
Delta 1.55% Profitability Increased
Previous 17.83%
Current 18.70%
Delta 0.88% R And D Intensity Increased
Previous 7.55%
Current 8.06%
Delta 0.52% Sbc Intensity Increased
Previous 0.99%
Current 1.08%
Delta 0.09% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.